Apalutamide & Targeted RadiationTreating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging

Sponsor:

ECOG-ACRIN Cancer Research Group

Code:

NCT04423211

Conditions

Biochemically Recurrent Prostate Carcinoma

Metastatic Prostate Carcinoma

Prostate Adenocarcinoma

Stage IVB Prostate Cancer AJCC v8

Eligibility Criteria

Sex: Male

Age: 18+

Healthy Volunteers: Not accepted

Interventions

3-Dimensional Conformal Radiation Therapy

Apalutamide

Computed Tomography

Degarelix

External Beam Radiation Therapy

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2026-08-23. This information was provided to ClinicalTrials.gov by ECOG-ACRIN Cancer Research Group on 2026-08-19.